Sidney Crosby Won’t Like This? Penguins’ Stunning Trade Move Has Fans Absolutely Erupting Online

This Saturday morning, the Pittsburgh Penguins exchanged Oliver Okuliar’s rights for Emil Pieniniemi to the Florida Panthers.

 

 

Renaud Lavoie, a TVA Sports insider, was the first to announce the transaction on X at 11:32 a.m. ET.

 

 

Although neither player has consistently played in the NHL this season, rights exchanges like this seldom concern the present.

 

They are about who will manage the asset in the future and what each front office believes it can accomplish with it.

 

 

The Penguins now have a forward alternative that they may develop on their own timeline, according to GM Kyle Dubas, who acquired Okuliar’s rights in Pittsburgh.

 

 

This season, the Penguins placed 10th in the league overall and 98 points with a record of 41-25-16.

 

 

With a trying season coming to a close, the Panthers are using their depth.

 

Florida had a worse year, finishing with 84 points overall and a 40-38-4 record, placing them 25th in the league.

 

 

This season, the Panthers scored just 251 goals while giving up 276, a -25 goal differential that clearly illustrates the narrative.

 

 

While the Crosby and Malkin period approaches its natural conclusion, Dubas is preparing for the next wave in Pittsburgh.

 

 

Buying a lottery ticket you discovered in someone else’s coat is like making a rights trade in June. Cheap, unsure of the payoff, yet you’re still happy you discovered it.

 

Florida receives Pieniniemi’s rights from GM Bill Zito, bringing a young defensive prospect to a roster that is in need of more depth at every position and is adjacent to a rebuild.

 

 

Since Pittsburgh defeated Florida 3-0 last season, including a 9-4 thrashing on April 4th, there isn’t any ill will to deal with.

 

 

This deal accurately represents two businesses that are moving in incredibly different directions.

 

 

Whether Okuliar will ever play for the Penguins is a question no one can answer at this moment.

Be the first to comment

Leave a Reply

Your email address will not be published.


*